Aceruloplasminemia
Journal:
Current Drug Targets
Volume:
13
Page:
1190-1199
Author(s):
Satoshi Kono
Lafora Progressive Myoclonus Epilepsy: Recent Insights into Cell Degeneration
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
6
Page:
99-107
Author(s):
Carlos Spuch, Saida Ortolano and Carmen Navarro
The Role of Peroxidation of Mitochondrial Membrane Phospholipids in Pancreatic β -Cell Failure
Journal:
Current Diabetes Reviews
Volume:
8
Page:
69-75
Author(s):
Zhongmin A. Ma
Involvement of Cytosolic Phospholipase A2, Calcium Independent Phospholipase A2 and Plasmalogen Selective Phospholipase A2 in Neurodegenerative and Neuropsychiatric Conditions
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
2746-2763
Author(s):
W.-Y. Ong, T. Farooqui and A.A. Farooqui
The Role of Phosphorylation in Synucleinopathies: Focus on Parkinsons Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
9
Page:
471-481
Author(s):
Nadia Cavallarin, Mattia Vicario and Alessandro Negro
Biophysics of Parkinsons Disease: Structure and Aggregation of α- Synuclein
Journal:
Current Protein & Peptide Science
Volume:
10
Page:
483-499
Author(s):
Vladimir N. Uversky and David Eliezer
Neurodegeneration in Niemann-Pick Type C Disease and Huntingtons Disease: Impact of Defects in Membrane Trafficking
Journal:
Current Drug Targets
Volume:
10
Page:
653-665
Author(s):
J. K. Schweitzer, J. P. Krivda and C. D'Souza-Schorey
α-Synuclein Misfolding and Neurodegenerative Diseases
Journal:
Current Protein & Peptide Science
Volume:
9
Page:
507-540
Author(s):
Vladimir N. Uversky
β-Synuclein Assembly as a Therapeutic Target of Parkinsons Disease and Related Disorders
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
3247-3266
Author(s):
Kenjiro Ono, Mie Hirohata and Masahito Yamada
Group VI Phospholipases A2: Homeostatic Phospholipases with Significant Potential as Targets for Novel Therapeutics
Journal:
Current Drug Targets
Volume:
9
Page:
683-697
Author(s):
W. P. Wilkins III and S. E. Barbour